Related Experiment Video

Updated: Aug 14, 2026

Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty
05:53

Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty

Published on: July 24, 2013

Hypertension in HIV-infected patients: prevalence and related factors

Carlos Jericó1, Hernando Knobel, Milagro Montero

  • 1Department of Medicine, Hospital del Mar, Universidad Autónoma de Barcelona, Barcelona, Spain.

American Journal of Hypertension
|November 11, 2005
PubMed

Insights

Hypertension prevalence is similar in HIV-infected patients and controls. Key factors like age, BMI, and fat redistribution patterns, not combination antiretroviral therapy, are linked to hypertension in HIV patients.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Public Health

Background:

  • Hypertension prevalence and contributing factors in HIV-infected individuals remain under-researched.
  • Understanding these factors is crucial for managing cardiovascular health in this population.

Purpose of the Study:

  • To determine the prevalence of hypertension among HIV-infected patients.
  • To identify factors associated with hypertension in the HIV-infected population.

Main Methods:

  • Prospective cross-sectional study involving 710 HIV-infected patients and 802 controls.
  • Data collection included medical examinations and a 6-month follow-up with three control visits.

Main Results:

  • Hypertension prevalence was comparable: 13.1% in HIV patients and 13.5% in controls.
  • Independent predictors of hypertension in HIV patients included age, body mass index, and lipoaccumulation pattern of fat redistribution.

Conclusions:

  • No significant difference in hypertension prevalence was observed between HIV-infected individuals and controls.
  • Combination antiretroviral therapy showed minimal impact on hypertension prevalence in this study.
Abstract

More Related Videos

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings19:57

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice06:07

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Published on: October 6, 2022

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Factors affecting Blood pressure01:28

Factors affecting Blood pressure

Several physiological and lifestyle factors influence blood pressure (BP). Understanding these factors is crucial as they are significant in patient education and blood pressure management.
Physiological Factors: